L. Wei

4.4k total citations · 1 hit paper
13 papers, 3.2k citations indexed

About

L. Wei is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L. Wei has authored 13 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L. Wei's work include Bioinformatics and Genomic Networks (2 papers), Cancer-related Molecular Pathways (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). L. Wei is often cited by papers focused on Bioinformatics and Genomic Networks (2 papers), Cancer-related Molecular Pathways (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). L. Wei collaborates with scholars based in China and United States. L. Wei's co-authors include Tommaso Cai, Atsushi Tajima, Joseph A. Demaro, Franz‐Josef Hans, J. Fenstermacher, Dawn E. W. Livingstone, Jiangtao Yu, Bao Song, Li Xie and Weijian Guo and has published in prestigious journals such as Nucleic Acids Research, Biomaterials and Hypertension.

In The Last Decade

L. Wei

12 papers receiving 3.2k citations

Hit Papers

Automated genome annotation and pathway identification us... 2005 2026 2012 2019 2005 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Wei China 8 1.6k 1.2k 454 284 281 13 3.2k
Zhixing Feng China 9 2.1k 1.3× 1.3k 1.1× 572 1.3× 368 1.3× 321 1.1× 13 3.8k
Jiaju Huang United States 9 2.0k 1.2× 1.2k 1.0× 609 1.3× 458 1.6× 358 1.3× 13 4.0k
Shan Dong China 18 2.3k 1.4× 1.2k 1.0× 632 1.4× 546 1.9× 370 1.3× 45 4.5k
Likun Wang China 17 2.5k 1.5× 1.4k 1.1× 584 1.3× 409 1.4× 375 1.3× 51 4.5k
Huan Wang China 26 1.3k 0.8× 1.1k 0.9× 528 1.2× 483 1.7× 131 0.5× 161 3.0k
Gang Zhou China 28 1.3k 0.8× 670 0.5× 324 0.7× 368 1.3× 279 1.0× 129 2.6k
Chuan‐Yun Li China 22 3.1k 1.9× 1.3k 1.1× 732 1.6× 643 2.3× 455 1.6× 49 5.4k
Dan Cheng China 27 861 0.5× 602 0.5× 285 0.6× 415 1.5× 343 1.2× 97 2.2k
Ravi K. Patel United States 18 2.2k 1.4× 1.5k 1.2× 359 0.8× 562 2.0× 314 1.1× 30 4.1k

Countries citing papers authored by L. Wei

Since Specialization
Citations

This map shows the geographic impact of L. Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Wei more than expected).

Fields of papers citing papers by L. Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Wei. The network helps show where L. Wei may publish in the future.

Co-authorship network of co-authors of L. Wei

This figure shows the co-authorship network connecting the top 25 collaborators of L. Wei. A scholar is included among the top collaborators of L. Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Wei. L. Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Huang, Jia, Xiaoqian Guo, L. Wei, et al.. (2024). An all-in-one therapeutic platform for the treatment of resistant Helicobacter pylori infection. Biomaterials. 308. 122540–122540. 7 indexed citations
3.
Wei, L., Miao Liu, Yujie Chen, et al.. (2024). Association of preoperative frailty with risk of postoperative delirium in older patients undergoing craniotomy: a prospective cohort study. BMC Surgery. 24(1). 272–272. 1 indexed citations
4.
Wei, L., et al.. (2014). Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize NSCLC cells to cisplatin. Cancer Gene Therapy. 21(5). 194–199. 16 indexed citations
5.
Xie, Li, et al.. (2013). Aldo-keto reductase 1C3 may be a new radioresistance marker in non-small-cell lung cancer. Cancer Gene Therapy. 20(4). 260–266. 28 indexed citations
6.
Zhao, H., Mei Guo, Xuedong Sun, et al.. (2012). Effects of recombinant human granulocyte colony-stimulating factor on central and peripheral T lymphocyte reconstitution after sublethal irradiation in mice. Journal of Radiation Research. 54(1). 83–91. 5 indexed citations
8.
Zhang, W., Y. Zhang, Hui Zheng, et al.. (2006). SynDB: a Synapse protein DataBase based on synapse ontology. Nucleic Acids Research. 35(Database). D737–D741. 40 indexed citations
9.
Cai, Tommaso, et al.. (2005). Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Computer applications in the biosciences. 21(19). 3787–3793. 2975 indexed citations breakdown →
10.
Wei, L., et al.. (2002). Study on the effects of FCu-IUD and FICu-IUD on matrix metalloproteinases in human uterine flushing and endometrium. Current Medical Science. 22(1). 9–12. 3 indexed citations
11.
Wei, L., et al.. (1999). Treatment of complications due to peritoneal dialysis for chronic renal failure with traditional Chinese medicine.. PubMed. 19(1). 3–9. 11 indexed citations
12.
Wei, L., et al.. (1997). Altered pHi regulation in 3T3/CFTR clones and their chemotherapeutic drug-selected derivatives. American Journal of Physiology-Cell Physiology. 272(5). C1642–C1653. 12 indexed citations
13.
Tajima, Atsushi, Franz‐Josef Hans, Dawn E. W. Livingstone, et al.. (1993). Smaller local brain volumes and cerebral atrophy in spontaneously hypertensive rats.. Hypertension. 21(1). 105–111. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026